The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Prevention is accepting applications for the FY 2018 Improving Access to Overdose Treatment (OD Treatment Access) program. SAMHSA will award OD Treatment Access funds to Federally Qualified Health Centers (FQHC), opioid treatment programs, or practitioners who have a waiver to prescribe buprenorphine. The program aims to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdoses. Recipients will partner with other prescribers at the community level to develop best practices for prescribing and co-prescribing FDA-approved overdose reversal drugs. After developing best practices, the recipients will train other prescribers in key community sectors as well as individuals who support persons at high risk for overdose.